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Objective
To highlight a successful method for improving recruit-
ment into a trial of a rare skin condition.
Background
Pyoderma gangrenosum (PG) is a rare, ulcerative condi-
tion that is often associated with underlying autoim-
mune disease. Most dermatologists in the UK only see
1-2 PG patients per annum, making this a very difficult
condition to evaluate empirically.
Methods
The STOP GAP trial is a randomised controlled trial
(RCT) of oral prednisolone compared to oral ciclosporin
for the treatment of PG. The study includes a parallel
observation study (case series) for patients requiring
topical therapy.
Patients who are enrolled into the observational study
continue to be followed up and contribute data relating
to the efficacy and acceptability of topical treatments.
These data provide an important contribution to the
available literature on PG, which to-date is based largely
on case reports and retrospective case series. An addi-
tional benefit of this approach is that patients remain in
contact with the research team, and should systemic
therapy be indicated, participants are considered for
inclusion into the RCT of systemic treatments. This
design is efficient and means that most patients who are
willing and able to give informed consent are able to
contribute to the research activity; this contributes to a
broader evidence-base for the treatment of PG patients.
Results
The STOP GAP trial is ongoing and has currently
enrolled 73/140 (52%) participants into the RCT, and 35
participants into the observational study. Five (14%) of
the patients given topical therapy (observational study)
have subsequently gone on to take part in the RCT, hav-
ing required systemic treatment.
Conclusions
Whilst it is more work to conduct an observational
study alongside an ongoingR C T ,a n dt h ea d d e dv a l u e
of these data is limited by the lack of a randomised
comparator, the benefits of this approach outweigh the
disadvantages when the condition of interest is rare, and
where the existing evidence base is poor.
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